Ppar gamma agonists for treatment of multiple sclerosis
AssigneeInteKrin Therapeutics, Inc.
InventorDavid Weinstein
Life of this patent
Estimating the term…
Abstract
Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:
Claims4
A method of treating multiple sclerosis in a patient in need thereof comprising administering to said patient at regular dosing intervals of a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I),
- or a pharmaceutically acceptable salt, prodrug, or isomer thereof
A method of treating the symptoms of multiple sclerosis comprising administering to a patient in need thereof a compound of formula (I),
- or a pharmaceutically acceptable salt, prodrug or isomer thereof
A method of providing neuroprotection to a patient in need thereof comprising administering a compound of the formula (I),
- or a pharmaceutically acceptable salt, prodrug or isomer thereof
A method of treating the symptoms of neuroinflammation comprising administering to a patient in need thereof a compound of formula (I),
- or a pharmaceutically acceptable salt, prodrug or isomer thereof
Dependencies are inferred from the claim text.